AEON Biopharma appoints John Bencich as CFO
Source: SeekingAlpha
2026-03-09 16:12:16 ET
More on AEON Biopharma
- AEON Biopharma announces execution of exchange agreement with Daewoong Pharmaceutical
- Seeking Alpha’s Quant Rating on AEON Biopharma
- Historical earnings data for AEON Biopharma
- Financial information for AEON Biopharma
Read the full article on Seeking Alpha
For further details see:
AEON Biopharma appoints John Bencich as CFO
AEON Biopharma Inc. Class A
NASDAQ: AEON
AEON Trading
-1.21% G/L:
$0.7284 Last:
7,013 Volume:
$0.7299 Open:
AEON Latest News
June 04, 2026 07:00:00 am
AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society
May 14, 2026 04:05:00 pm
AEON Biopharma Reports First Quarter 2026 Financial Results and Provides Corporate Update
April 03, 2026 04:05:00 pm
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
AEON Stock Data
$26,568,211
20,040,022
N/A
9
N/A
Biotechnology & Life Sciences
Healthcare
US
Irvine
